Internal Oncology Laboratory, Fujian Provincial Key Laboratory ofTranslational Medicine Oncology, Fujian Provincial Tumor Hospital, Fuzhou, Fujian, China;
Department of Pathology, Institute of Oncology, Fujian Medical University, Fuzhou, Fujian, China;
the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China;
Internal Oncology Laboratory, Fujian Provincial Key Laboratory ofTranslational Medicine Oncology, Fujian Provincial Tumor Hospital, Fuzhou, Fujian, China;
the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China;
Department of Pathology, Institute of Oncology, Fujian Medical University, Fuzhou, Fujian, China;
Department of Pathology, Institute of Oncology, Fujian Medical University, Fuzhou, Fujian, China;
the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China;
Internal Oncology Laboratory, Fujian Provincial Key Laboratory ofTranslational Medicine Oncology, Fujian Provincial Tumor Hospital, Fuzhou, Fujian, China;
the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China;
Internal Oncology Laboratory, Fujian Provincial Key Laboratory ofTranslational Medicine Oncology, Fujian Provincial Tumor Hospital, Fuzhou, Fujian, China;
mitochondrial; liver cancer; tissue; two-dimensional electrophoresis;
机译:对患者肝细胞癌的比较线粒体蛋白质组学分析
机译:年轻的肝细胞癌患者的预后是否比年长的患者预后差?临床特征,预后特征和生存结果的比较分析。
机译:年轻的肝细胞癌患者的预后是否比年长的患者预后差?临床特征,预后特征和生存结果的比较分析
机译:患者肝细胞癌的比较线粒体疫苗疫苗
机译:HCV阳性肝细胞癌患者肿瘤组织和非肿瘤组织表观遗传和基因表达终点的比较分析。
机译:非病毒性肝细胞癌患者的预后概况:使用数据挖掘分析与丙型肝炎病毒相关的肝细胞癌的比较研究
机译:肝细胞癌患者线粒体4977 bp缺失分析